BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33864292)

  • 21. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
    Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
    World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
    Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
    Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.
    Luo SP; Wu QS; Chen H; Wang XX; Chen QX; Zhang J; Song CG
    J Surg Res; 2020 Mar; 247():211-219. PubMed ID: 31706539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?
    Hari DM; Leung AM; Lee JH; Sim MS; Vuong B; Chiu CG; Bilchik AJ
    J Am Coll Surg; 2013 Aug; 217(2):181-90. PubMed ID: 23768788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
    Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
    Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.
    Chan AC; Fan ST; Poon RT; Cheung TT; Chok KS; Chan SC; Lo CM
    HPB (Oxford); 2013 Jun; 15(6):439-48. PubMed ID: 23659567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
    Basile G; Mattei JC; Alshaygy I; Griffin AM; Catton CN; Chung PW; Shultz DB; Razak ARA; Demicco EG; Ferguson PC; Wunder JS
    Cancer; 2020 Dec; 126(23):5098-5108. PubMed ID: 32910462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
    Cates JMM
    J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
    [No Abstract]   [Full Text] [Related]  

  • 31. Anatomic extent of lymph node metastases as an independent prognosticator in node-positive major salivary gland carcinoma: A study of the US SEER database and a Chinese multicenter cohort.
    Shi X; Liu XK; An CM; Wei WJ; Tao Y; Ji Y; Zhang Y; Han W; Xue JC; Huang NS; Ma B; Zhang CP; Yang X; Wang KJ; Liu QJ; Liu Y; Wang Y; Lei BW; Yu PC; Hu JQ; Lu ZW; Hu WP; Tian YX; Wang YL; Ji QH
    Eur J Surg Oncol; 2019 Nov; 45(11):2143-2150. PubMed ID: 31253544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database.
    Gao P; Song YX; Wang ZN; Xu YY; Tong LL; Sun JX; Yu M; Xu HM
    BMC Cancer; 2013 Mar; 13():123. PubMed ID: 23496812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Roche AM; Fedewa SA; Shi LL; Chen AY
    Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma.
    Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
    Ann Surg Oncol; 2021 Feb; 28(2):650-660. PubMed ID: 33025354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
    Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):331-339. PubMed ID: 30525210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.
    Kim HI; Kim K; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Ahn HS; Kim SW; Kim TH; Chung JH
    Oral Oncol; 2018 Mar; 78():80-86. PubMed ID: 29496063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel N Staging System for Predicting Survival in Patients with Medullary Thyroid Cancer.
    Chen L; Qian K; Guo K; Zheng X; Sun W; Sun T; Wang Y; Li D; Wu Y; Ji Q; Wang Z
    Ann Surg Oncol; 2019 Dec; 26(13):4430-4438. PubMed ID: 31552613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
    Suh S; Kim YH; Goh TS; Lee J; Jeong DC; Oh SO; Hong JC; Kim SJ; Kim IJ; Pak K
    Endocrine; 2017 Dec; 58(3):495-502. PubMed ID: 29030773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
    Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.